Sékouba Sidimé/LinkedIn
Jun 2, 2026, 19:42
Sékouba Sidimé: vWD vs Hemophilia A – The Classic USMLE Step 1 trap in Hematology
Sékouba Sidimé, Internal Medicine Physician, shared a post on LinkedIn:
“vWD vs Hemophilia A – The No. 1 USMLE Step 1 trap in Hematology
One lab result tells them apart.Here’s what you need to know:
von Willebrand Disease
- Prolonged aPTT, prolonged Bleeding time, decreased Ristocetin
- Female with a family history and mucocutaneous bleeding
- Treatment: Desmopressin (DDAVP)
Hemophilia A
- Prolonged aPTT , Bleeding time normal, Ristocetin normal
- Male with hemarthroses
- Treatment: Factor VIII replacement
The key:
vWF carries Factor VIII — decreased vWF results in secondary reduction of Factor VIII.
That’s why vWD affects both aPTT AND bleeding time.
Hemophilia A affects aPTT only.
If the examiner mentions Ristocetin then think vWD. Every time.”
Stay updated with Hemostasis Today.
-
Jun 5, 2026, 09:58Evaluating Anti-Xa Targets and Outcomes in Arterial Interventions – JTH
-
Jun 5, 2026, 08:27Morten Thaysen Andersen: Platelet Glycobiology and The Importance of FUT8 for Platelet Function
-
Jun 5, 2026, 08:10Michael Ertl: Air Pollution and Stroke – Which Patients Are Particularly at Risk?
-
Jun 5, 2026, 07:58Omid Seidizadeh: Pleasure to Present on VWD in Aging at the ERN-EuroBloodNet Webinar Series
-
Jun 5, 2026, 07:14Elissa Embrechts: A Small But Meaningful Step Towards Better Fall Risk Prediction in Stroke Rehabilitation
-
Jun 5, 2026, 03:27Lovish Garg: Restoring Venous Flow Through Catheter-Directed Thrombus Removal
-
Jun 5, 2026, 03:20Javed Anees: Anemia in Pregnancy Is Common, but Never Trivial
-
Jun 5, 2026, 02:52Andrada Seicean: Endoscopic Ultrasound and Portal Pressure Assessment in Patients Undergoing TIPS
-
Jun 5, 2026, 02:29Sam Tomy K: Antinuclear Antibody Testing and Its Role in Autoimmune Disease Diagnosis